
A recent study investigated the effectiveness of intense pulsed light (M22) in treating meibomian gland dysfunction (MGD) caused by demodex mites. The study involved 100 patients diagnosed with Demodex mites, randomly divided into experimental and control groups. Results after 8 weeks of treatment revealed that the M22 therapy group exhibited a significantly higher mite clearance rate (88.0% vs. 58.0%), dry eye cure rate (92.0% vs. 82.0%), and lower dry eye recurrence rate (13.04% vs. 26.83%) compared to the control group. This suggests that M22 therapy demonstrates superior efficacy in eradicating Demodex mites, treating dry eye, and maintaining long-term effectiveness in patients with MGD caused by Demodex mites.
Like
Save
Share